Psilocybin-assisted therapy (PAT) is an emerging intervention that combines the administration of psilocybin with structured psychological support to address profound psychological, emotional, and existential distress. Central to this model is the recognition that many forms of suffering-particularly at end of life-are relational in nature and require relational forms of healing. It is our...
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
ABSTRACT Psychedelic interventions are not publicly available through Canada's healthcare system. Despite growing scientific evidence, public interest, and efforts to expand access to psychedelic therapies for end‐of‐life psychological suffering, Canadian policies remain restrictive. Efforts are underway to expand access, but knowledge gaps exist regarding the policy landscape in Canada. This...
The escalating global burden of mental health disorders, coupled with the stagnation of innovation in traditional monoaminergic pharmacotherapy (e.g., SSRIs), has precipitated a critical need for novel therapeutic paradigms. This article presents a comprehensive systematic review of the so-called "Psychedelic Renaissance," focusing on the clinical resurgence of classical serotonergic...
Healthcare chaplains and clinicians increasingly encounter patients whose losses do not conclude: those in palliative trajectories, persons with progressive neurological disease, dementia caregivers, displaced persons, and incarcerated individuals.This article is a conceptual contribution that derives its construct from interdisciplinary literature rather than from new empirical data.The...
This research project presents a six-year autoethnographic case study examining recurrent sleep paralysis through the lens of lived experience. While sleep paralysis is commonly explained through neurophysiological mechanisms—particularly REM atonia intrusion—there remains a significant gap in qualitative literature capturing how the condition is experienced subjectively over time. The purpose...
Mindfulness-based interventions are gaining recognition as effective therapeutic tools for psychological distress in oncology. However, the widespread adoption of mindfulness in Western clinical contexts has raised ethical and philosophical concerns, particularly regarding the Westernisation and cultural appropriation of Buddhist wisdom. This paper examines the ethical implications of employing...
Reports of near-death experiences (NDEs), end-of-life visions (ELVs), and culturally embedded afterlife narratives frequently describe profoundly positive or distressing states. Traditional interpretations treat these phenomena as evidence of external metaphysical realms. The Dying-Moment Dream Hypothesis proposes an alternative, neurobiologically grounded explanation: that culturally...
Healthcare providers' (HCPs) perspectives on psychedelic-assisted therapy (PAT) are critical to clinical integration but remain underexplored in Canadian palliative and oncology contexts. This study examines HCP attitudes toward ketamine, psilocybin, and MDMA, and the systemic and ethical factors influencing implementation. An exploratory qualitative study using semi-structured interviews was...
ABSTRACT Objective Anxiety is common in patients receiving end‐of‐life care and significantly impacts their quality of life. However, pharmacological management remains challenging due to complex clinical presentations and potential side effects, emphasizing the need for systematically reviewing existing treatments. Here we aim to systematically evaluate the efficacy and safety of...